WO2025109556 - ROTATOR CUFF SYSTEM
National phase entry is expected:
Publication Number
WO/2025/109556
Publication Date
30.05.2025
International Application No.
PCT/IB2024/061742
International Filing Date
22.11.2024
Title **
[English]
ROTATOR CUFF SYSTEM
[French]
SYSTÈME DE MANCHON DE ROTATEUR
Applicants **
ANIKA THERAPEUTICS, INC.
CHAO, Nam
EK, Steven W.
BRIGHTMAN, Tim
LEDUC, Dan
BAKER, Chris
AGNELLO, Stefano
AHN, Edward
CENTOLA, Matteo
KENNEDY, Stephen J.
MANNARINO, Matthew M.
MARCHETTO, Elvira
PURI, Sonali
RICHARD, Robert
SIMONCIONI, Sara
GORALTCHOUK, Alex
Inventors
CHAO, Nam
EK, Steven W.
BRIGHTMAN, Tim
LEDUC, Dan
BAKER, Chris
AGNELLO, Stefano
AHN, Edward
CENTOLA, Matteo
KENNEDY, Stephen J.
MANNARINO, Matthew M.
MARCHETTO, Elvira
PURI, Sonali
RICHARD, Robert
SIMONCIONI, Sara
GORALTCHOUK, Alex
Priority Data
18/518,255
22.11.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6461 | |
| EPO | Filing, Examination, Granting | 54932 | |
| Japan | Filing, Examination, Granting | 3727 | |
| South Korea | Filing, Examination, Granting | 5112 | |
| USA | Filing, Examination, Granting | 16440 |
Total:
86,672
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Systems, methods, and devices for delivery of an implant to a targeted area of a subject. The systems may include the implant including a plurality of bioresorbable hyaluronan-based fibers and a plurality of non-resorbable fibers, a bone fastener configured to couple the implant to bone, a soft-tissue fastener configured to couple the implant to soft tissue. The systems may include a soft-tissue fastener tool (SFT) configured to couple with and deliver the soft-tissue fastener through the implant and soft-tissue and a bone fastener tool (BFT) configured to couple with and deliver the bone fastener and the implant. The BFT may further be configured to facilitate positioning of at least a portion of the implant over the targeted area after delivery thereto, and a cannula including a cannula passage configured to receive the BFT coupled with the bone fastener and implant therethrough.[French]
L'invention concerne des systèmes, des procédés et des dispositifs pour l'administration d'un implant à une zone ciblée d'un sujet. Les systèmes peuvent comprendre l'implant comprenant une pluralité de fibres à base d'hyaluronane biorésorbables et une pluralité de fibres non résorbables, un élément de fixation d'os configuré pour coupler l'implant à l'os, un élément de fixation de tissu mou configuré pour coupler l'implant à un tissu mou. Les systèmes peuvent comprendre un outil de fixation de tissu mou (SFT) configuré pour s'accoupler avec et distribuer l'élément de fixation de tissu mou à travers l'implant et le tissu mou et un outil de fixation d'os (BFT) configuré pour s'accoupler avec et distribuer l'élément de fixation d'os et l'implant. Le BFT peut en outre être configuré pour faciliter le positionnement d'au moins une partie de l'implant sur la zone ciblée après son administration, et une canule comprenant un passage de canule conçu pour recevoir le BFT couplé à l'élément de fixation d'os et à l'implant à travers celui-ci.